[Preliminary trials with a new psychamine (A 66, 2-phenyl-3-methyl-tetrahydro-1,4-oxazine) in the treatment of obesity].
D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D009025:Morpholines; D009765:Obesity / Q000628:therapy*; D010078:Oxazines
D000697:Central Nervous System Stimulants; D009025:Morpholines; D010078:Oxazines
ANALEPTICS/therapeutic use; OBESITY/therapy
Essai préliminaire d'une nouvelle psychamine (A 66) dans le traitement de l'obésité; le 2-phényl-3-méthyl-tétrahydro 1,4-oxazine.